Relationship of the anxiety-depressive disorder with coronary heart disease, comorbid with metabolic syndrome

by N. S. Michaylovskaya, V. A. Litvinenko, A. I. Melnik
Published 2015-10-01

VENTRICULAR EXTRASYSTOLY WITH HIGH RISK OF LIFE-THREATENING ARRHYTHMIAS DEVELOPMENT IN ACUTE CORONARY SYNDROME WITHOUT ST ELEVATION: EVALUATION OF REVASCULARIZATION EFFECTIVENESS

by A. I. Olesin, V. A. Litvinenko, A. B. Al-Barbari, T. L. Tikhonova
Published 2014-11-01

A POSSIBILITY TO USE ANTIARRHYTHMIC MEDICATIONS FROM II CLASS AND MODULATED KINESITHERAPY AS PRIMARY PREVENTION OF ATRIAL FIBRILLATION IN METABOLIC SYNDROME PATIENTS

by A. I. Olesin, V. A. Litvinenko, I. V. Konstantinova, A. V. Shlapakova
Published 2015-11-01

CLINICAL ASSESSMENT OF LIFE-THREATENING VENTRICULAR ARRHYTHMIA PREDICTORS IN PATIENTS WITH VENTRICULAR EXTRASYSTOLIA AND NO MORPHOLOGICAL HEART PATHOLOGY (A PROSPECTIVE STUDY)

by A. I. Olesin, A. V. Koziy, E. V. Semenova, V. A. Litvinenko, A. V. Shabrov
Published 2010-02-01

ATRIAL FIBRILLATION ONSET RISK IN PATIENTS WITH METABOLIC SYNDROME: PROSPECTIVE STUDY

by A. I. Olesin, V. A. Litvinenko, A. V. Al-Barbari, I. V. Konstantinova, Z. Yu. Smolin, O. N. Prosyanikova
Published 2014-12-01